List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hereditary Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Hereditary Cancer Testing
1.2.3 Hereditary Non-cancer Testing
1.3 Market by Application
1.3.1 Global Hereditary Testing Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Laboratory
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hereditary Testing Market Perspective (2018-2029)
2.2 Hereditary Testing Growth Trends by Region
2.2.1 Hereditary Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hereditary Testing Historic Market Size by Region (2018-2023)
2.2.3 Hereditary Testing Forecasted Market Size by Region (2024-2029)
2.3 Hereditary Testing Market Dynamics
2.3.1 Hereditary Testing Industry Trends
2.3.2 Hereditary Testing Market Drivers
2.3.3 Hereditary Testing Market Challenges
2.3.4 Hereditary Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hereditary Testing Players by Revenue
3.1.1 Global Top Hereditary Testing Players by Revenue (2018-2023)
3.1.2 Global Hereditary Testing Revenue Market Share by Players (2018-2023)
3.2 Global Hereditary Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hereditary Testing Revenue
3.4 Global Hereditary Testing Market Concentration Ratio
3.4.1 Global Hereditary Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hereditary Testing Revenue in 2022
3.5 Hereditary Testing Key Players Head office and Area Served
3.6 Key Players Hereditary Testing Product Solution and Service
3.7 Date of Enter into Hereditary Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hereditary Testing Breakdown Data by Type
4.1 Global Hereditary Testing Historic Market Size by Type (2018-2023)
4.2 Global Hereditary Testing Forecasted Market Size by Type (2024-2029)
5 Hereditary Testing Breakdown Data by Application
5.1 Global Hereditary Testing Historic Market Size by Application (2018-2023)
5.2 Global Hereditary Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Hereditary Testing Market Size (2018-2029)
6.2 North America Hereditary Testing Market Size by Country (2018-2023)
6.3 North America Hereditary Testing Market Size by Country (2024-2029)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Hereditary Testing Market Size (2018-2029)
7.2 Europe Hereditary Testing Market Size by Country (2018-2023)
7.3 Europe Hereditary Testing Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hereditary Testing Market Size (2018-2029)
8.2 Asia-Pacific Hereditary Testing Market Size by Country (2018-2023)
8.3 Asia-Pacific Hereditary Testing Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Hereditary Testing Market Size (2018-2029)
9.2 Latin America Hereditary Testing Market Size by Country (2018-2023)
9.3 Latin America Hereditary Testing Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hereditary Testing Market Size (2018-2029)
10.2 Middle East & Africa Hereditary Testing Market Size by Country (2018-2023)
10.3 Middle East & Africa Hereditary Testing Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Myriad Genetics, Inc.
11.1.1 Myriad Genetics, Inc. Company Detail
11.1.2 Myriad Genetics, Inc. Business Overview
11.1.3 Myriad Genetics, Inc. Hereditary Testing Introduction
11.1.4 Myriad Genetics, Inc. Revenue in Hereditary Testing Business (2018-2023)
11.1.5 Myriad Genetics, Inc. Recent Development
11.2 Invitae Corporation
11.2.1 Invitae Corporation Company Detail
11.2.2 Invitae Corporation Business Overview
11.2.3 Invitae Corporation Hereditary Testing Introduction
11.2.4 Invitae Corporation Revenue in Hereditary Testing Business (2018-2023)
11.2.5 Invitae Corporation Recent Development
11.3 Illumina, Inc.
11.3.1 Illumina, Inc. Company Detail
11.3.2 Illumina, Inc. Business Overview
11.3.3 Illumina, Inc. Hereditary Testing Introduction
11.3.4 Illumina, Inc. Revenue in Hereditary Testing Business (2018-2023)
11.3.5 Illumina, Inc. Recent Development
11.4 Natera, Inc.
11.4.1 Natera, Inc. Company Detail
11.4.2 Natera, Inc. Business Overview
11.4.3 Natera, Inc. Hereditary Testing Introduction
11.4.4 Natera, Inc. Revenue in Hereditary Testing Business (2018-2023)
11.4.5 Natera, Inc. Recent Development
11.5 Laboratory Corporation of America Holdings
11.5.1 Laboratory Corporation of America Holdings Company Detail
11.5.2 Laboratory Corporation of America Holdings Business Overview
11.5.3 Laboratory Corporation of America Holdings Hereditary Testing Introduction
11.5.4 Laboratory Corporation of America Holdings Revenue in Hereditary Testing Business (2018-2023)
11.5.5 Laboratory Corporation of America Holdings Recent Development
11.6 F. Hoffmann-La Roche Ltd
11.6.1 F. Hoffmann-La Roche Ltd Company Detail
11.6.2 F. Hoffmann-La Roche Ltd Business Overview
11.6.3 F. Hoffmann-La Roche Ltd Hereditary Testing Introduction
11.6.4 F. Hoffmann-La Roche Ltd Revenue in Hereditary Testing Business (2018-2023)
11.6.5 F. Hoffmann-La Roche Ltd Recent Development
11.7 Quest Diagnostics Incorporated
11.7.1 Quest Diagnostics Incorporated Company Detail
11.7.2 Quest Diagnostics Incorporated Business Overview
11.7.3 Quest Diagnostics Incorporated Hereditary Testing Introduction
11.7.4 Quest Diagnostics Incorporated Revenue in Hereditary Testing Business (2018-2023)
11.7.5 Quest Diagnostics Incorporated Recent Development
11.8 CooperSurgical, Inc.
11.8.1 CooperSurgical, Inc. Company Detail
11.8.2 CooperSurgical, Inc. Business Overview
11.8.3 CooperSurgical, Inc. Hereditary Testing Introduction
11.8.4 CooperSurgical, Inc. Revenue in Hereditary Testing Business (2018-2023)
11.8.5 CooperSurgical, Inc. Recent Development
11.9 Agilent Technologies, Inc.
11.9.1 Agilent Technologies, Inc. Company Detail
11.9.2 Agilent Technologies, Inc. Business Overview
11.9.3 Agilent Technologies, Inc. Hereditary Testing Introduction
11.9.4 Agilent Technologies, Inc. Revenue in Hereditary Testing Business (2018-2023)
11.9.5 Agilent Technologies, Inc. Recent Development
11.10 Thermo Fisher Scientific, Inc.
11.10.1 Thermo Fisher Scientific, Inc. Company Detail
11.10.2 Thermo Fisher Scientific, Inc. Business Overview
11.10.3 Thermo Fisher Scientific, Inc. Hereditary Testing Introduction
11.10.4 Thermo Fisher Scientific, Inc. Revenue in Hereditary Testing Business (2018-2023)
11.10.5 Thermo Fisher Scientific, Inc. Recent Development
11.11 Twist Bioscience
11.11.1 Twist Bioscience Company Detail
11.11.2 Twist Bioscience Business Overview
11.11.3 Twist Bioscience Hereditary Testing Introduction
11.11.4 Twist Bioscience Revenue in Hereditary Testing Business (2018-2023)
11.11.5 Twist Bioscience Recent Development
11.12 Sophia Genetics
11.12.1 Sophia Genetics Company Detail
11.12.2 Sophia Genetics Business Overview
11.12.3 Sophia Genetics Hereditary Testing Introduction
11.12.4 Sophia Genetics Revenue in Hereditary Testing Business (2018-2023)
11.12.5 Sophia Genetics Recent Development
11.13 Fulgent Genetic, Inc.
11.13.1 Fulgent Genetic, Inc. Company Detail
11.13.2 Fulgent Genetic, Inc. Business Overview
11.13.3 Fulgent Genetic, Inc. Hereditary Testing Introduction
11.13.4 Fulgent Genetic, Inc. Revenue in Hereditary Testing Business (2018-2023)
11.13.5 Fulgent Genetic, Inc. Recent Development
11.14 Medgenome
11.14.1 Medgenome Company Detail
11.14.2 Medgenome Business Overview
11.14.3 Medgenome Hereditary Testing Introduction
11.14.4 Medgenome Revenue in Hereditary Testing Business (2018-2023)
11.14.5 Medgenome Recent Development
11.15 CENTOGENE
11.15.1 CENTOGENE Company Detail
11.15.2 CENTOGENE Business Overview
11.15.3 CENTOGENE Hereditary Testing Introduction
11.15.4 CENTOGENE Revenue in Hereditary Testing Business (2018-2023)
11.15.5 CENTOGENE Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
